Treatments to reduce inflammation could help make HIV even less of a threat to health than antiretrovirals can alone.
December 22, 2017
____________________________________________________________________________________
____________________________________________________________________________________
For people with HIV on antiretrovirals (ARVs) who have a moderately
compromised immune system, serious cases of illnesses related to
inflammation are a central concern. Consequently, treatments that dampen
inflammation may make HIV even less of a threat to health than ARV
treatment can on its own.
Publishing their findings in
the Journal of Acquired Immune Deficiency Syndromes, researchers
analyzed data on 3,568 members of the control arms of the SMART or
ESPRIT studies who were on ARV treatment for HIV and had a viral load
between 300 and 500. The participants were followed for serious (grade
4) cases of various serious non-AIDS-defining health conditions, AIDS,
cardiovascular disease (CVD), non-AIDS-defining cancer (NADC) and death.
The researchers classified the grade 4 events based on whether they
reflected inflammation-related disease or non-inflammation-related
disease.
The researchers also looked at the
participants’ initial levels of an inflammatory marker known as
interleukin-6 (IL-6) as well as a marker of coagulation (blood clotting)
called D-dimer.
During a median follow-up of 4.3
years, 339 participants developed a grade 4 health event, for a rate of
2.29 percent per year, including 165 people who developed a grade 4
health event reflecting inflammation-related disease (for a rate of 1.07
percent per year). Overall grade 4 events were more common than AIDS
(diagnosed in 54 participants), CVD (132 participants) and NADC (80
participants), health outcomes that developed in 252 participants all
told, for a cumulative rate of 1.71 percent per year.
Forty-nine
percent of grade 4 health events were those reflecting
inflammation-related disease, including gastroenteritis (stomach flu),
cirrhosis of the liver, acute kidney failure and acute pancreatitis. The
most common grade 4 events not reflecting inflammation-related disease
were depression, back pain, groin hernia and suicide attempt.
Grade 4 health events and AIDS were associated with similar risks of death.
Having
a higher IL-6 level at the study’s outset was associated with 1.19-fold
increased risk of grade 4 health events for every comparative doubling
of the inflammatory marker’s level. And similarly, every comparative
doubling of the baseline D-dimer level was associated with a 1.23-fold
increased risk of grade 4 health events. The association between
baseline IL-6 level and grade 4 health events was stronger for events
reflecting inflammation-related disease (associated with a 1.38-fold
increased risk for each comparative doubling of the initial level)
compared with those reflecting non-inflammation-related disease
(associated with a 1.11-fold increased risk for each comparative
doubling of the initial level).
“Our findings showed
that potentially life-threatening conditions associated with the
activation of inflammatory and coagulation pathways due to HIV are more
extensive than AIDS and [serious non-AIDS health events] which
heretofore have been considered,” the study authors concluded.
To read the study abstract, click here.
More from POZ, here
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.